You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
Title |
Randomized controlled phase 2 trial of hydroxychloroquine in childhood interstitial lung disease
|
---|---|
Published in |
Orphanet Journal of Rare Diseases, July 2022
|
DOI | 10.1186/s13023-022-02399-2 |
Pubmed ID | |
Authors |
Matthias Griese, Matthias Kappler, Florian Stehling, Johannes Schulze, Winfried Baden, Cordula Koerner-Rettberg, Julia Carlens, Freerk Prenzel, Lutz Nährlich, Andreas Thalmeier, Daniela Sebah, Kai Kronfeld, Hans Rock, Christian Ruckes, Martin Wetzke, Elias Seidl, Nicolaus Schwerk |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 30 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 30 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Postgraduate | 3 | 10% |
Student > Bachelor | 2 | 7% |
Unspecified | 2 | 7% |
Lecturer > Senior Lecturer | 1 | 3% |
Student > Ph. D. Student | 1 | 3% |
Other | 3 | 10% |
Unknown | 18 | 60% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 6 | 20% |
Unspecified | 2 | 7% |
Biochemistry, Genetics and Molecular Biology | 1 | 3% |
Chemical Engineering | 1 | 3% |
Sports and Recreations | 1 | 3% |
Other | 1 | 3% |
Unknown | 18 | 60% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 July 2022.
All research outputs
#18,535,896
of 22,957,478 outputs
Outputs from Orphanet Journal of Rare Diseases
#2,159
of 2,636 outputs
Outputs of similar age
#299,611
of 431,936 outputs
Outputs of similar age from Orphanet Journal of Rare Diseases
#85
of 114 outputs
Altmetric has tracked 22,957,478 research outputs across all sources so far. This one is in the 11th percentile – i.e., 11% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,636 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 7.6. This one is in the 5th percentile – i.e., 5% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 431,936 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 20th percentile – i.e., 20% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 114 others from the same source and published within six weeks on either side of this one. This one is in the 5th percentile – i.e., 5% of its contemporaries scored the same or lower than it.